Advertisement

Topics

Bristol-Myers Squibb to sell APIs manufacturing facility in Ireland

19:00 EDT 19 Jun 2017 | Pharmaceutical Technology

Bristol-Myers Squibb (BMS) has signed a definitive purchase agreement to divest its small-molecule active pharmaceutical ingredient production facility in Swords, Ireland, to South Korean firm SK Biotek.

Original Article: Bristol-Myers Squibb to sell APIs manufacturing facility in Ireland

NEXT ARTICLE

More From BioPortfolio on "Bristol-Myers Squibb to sell APIs manufacturing facility in Ireland"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...